Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
This study has been completed.
Study NCT00000559 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Postmenopause
Additional conditions recognized in this trial
Coronary Artery Disease
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
estrogen replacement therapy
hormone replacement therapy
estradiol
medroxyprogesterone
Additional drug interventions recognized in this trial
Estrogens
Hormones
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
